SIRT1 and Hepatic fibrosis: Additionally, carvacrol and cilostazol co-administration was found to ameliorate ethanol-induced liver fibrosis through the SIRT1/Nrf2/HO-1 pathway, exerting antioxidant, anti-inflammatory, and anti-apoptotic effects (Abu-Risha et al., 2023).